Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5675-5682

  Maioli, Mario ^a   Alejandro, Emilyn ^b   Tonolo, Giancarlo ^a   Gilliam, Lisa K ^b   Bekris, Lynn ^b   Hampe, Christiane S ^b   Obinu, Domenica A ^a   Manconi, Alberto ^a   Puddu, Loreta ^a   Lynch, Kristian ^b   Lernmark, Åke ^a,b  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; EPITOPE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN DOMAIN;

ADULT; AGED; AUTOANTIBODIES; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EPITOPES; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PHENOTYPE;

EID: 8744245275     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0864     Document Type: Article

References (59)

1. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P 1990 Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156
2. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, Bärmeier H, Mathewes S, Grant FJ, Foster D, Lernmark Å 1991 Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 88:8337-8341
3. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark Å 1994 A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350
4. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paguette TL 1983 Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337-1339
5. Lan MS, Lu J, Goto Y, Notkins AL 1994 Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13:505-514
6. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PM 1994 Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152:3183-3187
7. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS 1996 Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933
8. Mire-Sluis AR, Das RG, Lernmark Å 2000 The World Health Organization International Collaborative Study for Islet Cell Antibodies. Diabetologia 43: 1282-1292
9. Bingley PJ, Bonifacio E, Mueller PW 2003 Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 52:1128-1136
10. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS 1998 Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866
11. Rolandsson O, Hägg E, Hampe C, Sullivan EP, Nilsson M, Jansson G, Hallmans G, Lernmark A 1999 Levels of glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies in the general population are related to glucose intolerance and body mass index. Diabetologia 42:555-559
12. Williams AJ, Bingley PJ, Moore WP, Gale EA 2002 Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with type I diabetes. Diabetologia 45:217-223
13. Irvine WJ, McCallum CJ, Gray RS, Campbell CJ, Duncan LJP, Farquhar JW, Vaughan H, Morris PJ 1977 Pancreatic islet cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease and HLA-type. Diabetes 26:138-147
14. Irvine WJ, Sawers JS, Peek CM, Prescott RJ, Duncan JP 1979 The value of islet cell antibody in predicting secondary failure of oral hypoglycemic agent therapy in diabetes mellitus. J Clin Immunol 2:23-26
15. Gleichmann H, Zörcher B, Greulich B 1984 Correlation of islet cell antibodies and HLR-DR phenotypes with diabetes mellitus in adults. Diabetologia 27: 90-92
16. Groop LC, Bottazzo GF, Doniac D 1986 Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-241
17. Niskanen L, Karjalainen J, Sarlund H, Siitonen O, Uusitupa M 1991 Five-year follow-up of islet cell antibodies in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:402-408
18. Landin-Olsson M, Nilsson KO, Lernmark A, Sundkvist G 1990 Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33:561-568
19. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark Å 1993 Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368-374
20. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR 1993 Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362
21. Lohmann T, Kellner K, Verlohren HJ, Krug J, Steindorf J, Scherbaum WA, Seissler J 2001 Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44:1005-1010
22. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC 1999 Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157
23. Falorni A, Gambelunghe G, Forini F, Kassi G, Cosentino A, Candeloro P, Bolli GB, Brunetti P, Calcinaro F 2000 Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 85:309-316
24. Pietropaolo M, Barinas-Mitchell E, Pietropaolo SL, Kuller LH, Trucco M 2000 Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes 49:32-38
25. Borg H, Gottsater A, Fernlund P, Sundkvist G 2002 A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51:1754-1762
26. Gottsater A, Landin-Olsson M, Lernmark Å, Fernlund P, Sundkvist G, Hagopian WA 1995 Glutamate decarboxylase antibody levels predict rate of β-cell decline in adult onset diabetes. Diabetes Res Clin Pract 27:133-140
27. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R 1997 UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288-1293
28. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA 1994 Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303
29. Juneja R, Hirsch IB, Naik RG, Brooks-Worrell BM, Greenbaum CJ, Palmer JP 2001 Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 50:1008-1013
30. Zimmet P, Alberti KG, Shaw J 2001 Global and societal implications of the diabetes epidemic. Nature 41:782-787
31. Mohatt J, Gilliam LK, Bekris L, Ebbesson S, Lernmark A 2002 Type 1 diabetes-related autoantibodies are rare in Alaska native populations. Int J Circumpolar Health 61:21-31
32. Dabelea D, Palmer JP, Bennett PH, Pettitt DJ, Knowler WC 1999 Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus. Diabetologia 42:1265-1266
33. Bosi E, Garancini M PF, Bonifacio E, Gallus G 1999 Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general population of northern Italy. Diabetologia 42:840-844
34. Soriguer-Escofet F, Esteva I, Rojo-Martinez G, Ruiz de Adana S, Catala M, Merelo MJ, Aguilar M, Tinahones F, Garcia-Almeida JM, Gomez-Zumaquero JM, Cuesta-Munoz AL, Ortego J, Freire JM 2002 Prevalence of latent autoimmune diabetes of adults (LADA) in Southern Spain. Diabetes Res Clin Pract 56:213-220
35. Takeda H, Kawasaki E, Shimizu I, Konoue E, Fujiyama M, Murao S, Tanaka K, Mori K, Tarumi Y, Seto I, Fujii Y, Kato K, Kondo S, Takada Y, Kitsuki N, Kaino Y, Kida K, Hashimoto N, Yamane Y, Yamawaki T, Onuma H, Nishimiya T, Osawa H, Saito Y, Makino H 2002 Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care 25:995-1001
36. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MI 1995 GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 18:1557-1565
37. Rolandsson O, Hägg E, Nilsson M, Hallmans G, Lernmark Å 2001 Prediction of diabetes by screening with body mass index, oral glucose tolerance test (OGT) and islet cell autoantibodies in a regional population. J Intern Med 249:279-288
38. Batstra MR, Petersen JS, Bruining GJ, Grobbee DE, de Man SA, Molenaar JL, Dyrberg T, Aanstoot HJ 2001 Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of The Netherlands. Hum Immunol 62:1106-1110
39. Hampe CS, Kockum I, Landin-Olsson M, Torn C, Ortqvist E, Persson B, Rolandsson O, Palmer J, Lernmark A 2002 GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes. Diabetes Care 25:1481-1482
40. Falorni A, Ackefors M, Carlberg C, Daniels T, Persson B, Robertson J, Lernmark Å 1996 Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies epitopes in childhood IDDM. Diabetologia 39:1091-1098
41. Bonifacio E, Lampasona V, Bernasconi L, Ziegler AG 2000 Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes 49:202-208
42. Teoh KL, Fida S, Rowley MJ, Mackay IR 1998 Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585). Autoimmunity 28:259-266
43. Kobayashi T, Tanaka S, Okubo M, Nakanishi K, Murase T, Lernmark A 2003 Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab 88:4768-4775
44. Maioli M, Tonolo G, Bekris L, Cirillo R, Schranz D, Cossu E, Ciccarese M, Lernmark Å 2002 GAD65 and IA-2 autoantibodies are common in siblings of Sardinia type 2 diabetic families. Diabetes Res Clin Pract 56:41-47
45. Muntoni S, Songini M 1992 High incidence rate of IDDM in Sardinia. Sardinian Collaborative Group for Epidemiology of IDDM. Diabetes Care 15: 1317-1322
46. Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Torn C, Persson B, Lernmark A 2000 Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes. J Clin Endocrinol Metab 85:4671-4679
47. Michelsen BK, Petersen JS, Boel E, Møldrup A, Dyrberg T, Madsen OD 1991 Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent mellitus. Proc Natl Acad Sci USA 88:8754-8758
48. Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Persson B, Lernmark A 2002 Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset. J Autoimmun 18:49-53
49. Daw K, Ujihara N, Atkinson M, Powers AC 1996 Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156: 818-825
50. Schwartz HL, Chandonia JM, Kash SF, Kanaani J, Tunnell E, Domingo A, Cohen FE, Banga JP, Madec AM, Richter W, Baekkeskov S 1999 High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 287:983-999
51. Fisher LD, Van Belle G 1993 Biostatistics: a methodology for the health sciences. New York: John Wiley, Sons
52. Notkins AL, Lernmark Å 2001 Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 108:1247-1252
53. Weets I, Van Autreve J, Van der Auwera BJ, Schuit FC, Du Caju MV, Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Dorchy H, Quartier E, Gorus FK 2001 Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index. Diabetologia 44:40-47
54. Landin-Olsson M, Arnqvist HJ, Blohme G, Littorin B, Lithner F, Nystrom L, Schersten B, Sundkvist G, Wibell L, Ostman J, Lernmark A 1999 Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus. Autoimmunity 29:57-63
55. Zimmet P, Turner R, McCarty D, Rowley M, Mackay I 1999 Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care 22(Suppl 2):B59-B64
56. Schranz D, Lernmark Å 1998 Immunology in diabetes: an update. Diabetes Metab Rev 14:3-29
57. Redondo MJ, Eisenbarth GS 2002 Genetic control of autoimmunity in type I diabetes and associated disorders. Diabetologia 45:605-622
58. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohme G 2002 Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 51:1346-1355
59. Richter W, Shi Y, Bækkeskov S 1993 Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 90:2832-2836